“A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma”

Proud to see our latest work published by the British Journal of Cancer: https://lnkd.in/djxJhGQ.
We proposed a migrastatic drug development pipeline. As part of the pipeline, we provide a new traceable spontaneous melanoma metastasis model for in vivo quantification of metastasis and anti-metastatic effects by non-invasive imaging.

This was a fantastic team effort between Vicky Sanz Moreno‘s team at Barts Cancer Institute and ourselves at King’s College London – Massive THANKS to everybody involved!
#cancerresearch #metastasis #drugdiscovery #imaging #celltracking #skincancer